Skip to content

Author

Hidefumi Nakamura

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Efficacy and Safety of Luseogliflozin (TS-071) in Japanese Children and Adolescents with Type 2 Diabetes Mellitus: A Multicenter, Randomized, Double-masked, Placebo-controlled Phase 3 Study.

INTRODUCTION This study evaluated the efficacy and safety of luseogliflozin (TS-071), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, in Japanese children and adolescents with type 2 diabetes (T2D). METHODS In this multicenter, randomized, double-masked, placebo-controlled phase 3 trial, patients aged 10-17 years...

T. Kikuchi, Hidefumi Nakamura, Hideo Umeuchi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.